Table 2 Difference in cell surface markers from mesenchymal stem cells exploited in clinical trials
Trials | Positive | Negative | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CD29 | CD73 | CD90 | CD105 | CD44 | CD45 | CD34 | CD11b | CD14 | CD79 | HLA-DR | |
Bone Marrow | |||||||||||
Liang,2010 [24] | ● | — | ● | ● | ● | ○ | ○ | — | ○ | — | — |
Wang,2013 [26] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Gu,2014 [28] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Makhlough, 2017 [32] | — | ● | ● | ● | ● | ○ | ○ | ○ | — | — | — |
Makhlough, 2018 [34] | — | ● | ● | ● | ● | ○ | ○ | ○ | — | — | — |
Chun,2022 [37] | ● | ● | ● | ● | ● | ○ | ○ | — | — | — | ○ |
Perico,2023 [38] | — | ● | ● | ● | — | ○ | ○ | — | — | — | — |
Umbilical Cord | |||||||||||
Sun,2010 [23] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Wang,2013 [26] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Wang,2014 [27] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Yuan,2019 [35] | ● | ● | ● | ● | — | ○ | ○ | — | ○ | ○ | ○ |
Adipose | |||||||||||
Ranjbar,2022 [36] | — | ● | ● | ● | ● | ○ | ○ | — | ○ | — | ○ |